United States Lancet and Lancing Devices Market Report 2016-2017 with Diabetes Monitoring, Treatment And Drug Delivery Market Overview - Research and Markets

DUBLIN, Nov 30, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "US Market Report for Lancet and Lancing Devices 2017 - MedCore" report to their offering.

The lancet and lancing device market can be segmented by setting, yielding two segments: personal and professional. In 2016, the largest segment in the total lancet and lancing device market was the personal segment. Personal lancets and lancing devices are used by individuals who use personal meters to perform self-monitoring blood glucose (SMBG) on a daily basis.

CMS competitive bidding had a significant impact on the personal lancet and lancing device market after substantial reimbursement cuts in July 2013 and July 2016, respectively.

Lancet reuse is also a limiter of growth in the personal segment. The professional market comprises safety lancets, which are used by clinicians and staff in the hospital or long term care settings to measure the blood glucose levels of their diabetic patients. Safety lancets are necessary to avoid the risk of needlestick injuries and the spread of blood-borne pathogens.

Key Topics Covered:

1. Executive Summary
U.S. Diabetes Monitoring, Treatment And Drug Delivery Market Overview
Competitive Analysis
Market Trends
Market Developments
Procedure Numbers
Procedure Codes Investigated
Markets Included
Key Report Updates
Version History

2. Disease Overview
2.1 Introduction
2.1.1 Types Of Diabetes
2.1.2 Diabetes Complications
2.1.3 Risk Factors Associated With Type 1 And Type 2 Diabetes
2.1.4 Signs And Symptoms
2.1.5 Diabetes Monitoring
2.1.6 Treatment
2.1.7 Drug Delivery Systems

3. Lancet And Lancing Device Market
3.1 Introduction
3.2 Market Overview
3.3 Market Analysis And Forecast
3.3.1 Total Lancet And Lancing Device Market
3.3.1.1 Personal Lancet And Lancing Device Market
3.3.1.2 Professional Lancet And Lancing Device Market
3.4 Drivers And Limiters
3.4.1 Market Drivers
3.4.2 Market Limiters
3.5 Competitive Market Share Analysis

Companies Mentioned

• Sanofi
• Novo Nordisk
• Eli Lilly
• Medtronic
• Johnson & Johnson
• Becton Dickinson
• Abbott
• Roche
• DexCom
• Ascensia
• Insulet
• Trividia Health
• Tandem
• Nova Biomedical
• Valeritas
  

For more information about this report visit http://www.researchandmarkets.com/research/5lhhf8/us_market_report

Media Contact:

Laura Wood, Senior Manager
[email protected] 

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com